Aurora Cannabis (ACB) Net Cash Flow (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Net Cash Flow of $2.4 million for Q1 2026, down 49.7% year-on-year from $4.8 million in Q1 2025, and down 88.69% on a QoQ basis from $21.3 million in Q4 2025.
Aurora Cannabis (ACB) Net Cash Flow (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Net Cash Flow for 10 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- Quarterly Net Cash Flow fell 49.7% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.8 million (up 193.27% YoY) and the FY2026 annual result came in at -$54.8 million, down 856.09% from the prior year.
- Net Cash Flow retreated to $2.4 million in Q1 2026 per ACB's latest filing, from $21.3 million in the prior quarter.
- Over the last five years, Net Cash Flow for ACB reached as high as $79.3 million in Q1 2022 and fell as low as -$182.7 million in Q4 2022.
- A 5-year average of -$13.5 million and a median of $2.4 million in 2026 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 2009.05% — and 2025, when it surged 121.47%.
- Year by year, Net Cash Flow stood at -$182.7 million in 2022, then surged by 106.75% to $12.3 million in 2023, then surged by 42.46% to $17.6 million in 2024, then advanced by 21.54% to $21.3 million in 2025, then tumbled by 88.69% to $2.4 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $2.4 million, $21.3 million, and $4.8 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.41 Mn |
| Mar 31, 2026 | 2.41 Mn |
| Dec 31, 2025 | 21.34 Mn |
| Dec 31, 2025 | 21.34 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Mar 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | 17.56 Mn |
| Dec 31, 2024 | 17.56 Mn |
| Sep 30, 2024 | -18.01 Mn |
| Sep 30, 2024 | -18.01 Mn |
| Jun 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 3.75 Mn |
| Mar 31, 2024 | -22.35 Mn |
| Mar 31, 2024 | -22.35 Mn |
| Dec 31, 2023 | 12.33 Mn |
| Dec 31, 2023 | 12.33 Mn |
| Sep 30, 2023 | -23.22 Mn |
| Sep 30, 2023 | -23.22 Mn |
| Dec 31, 2022 | -182.70 Mn |
| Dec 31, 2022 | -182.70 Mn |